BackStereotaxis Overview
Stereotaxis Inc

Stereotaxis Target Price

Analysts' average 12-month price target for Stereotaxis is $3.5.

Get informed when a big investor buys or sells

+ Follow

Share Price

$1.39

Average Target Price

$3.50151.8% upside

1 analysts in the last 4 months

High: $3.5 | Low: $3.5

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-13Piper Sandler$3.5151.8% upsideOpen
2025-11-05UBS$4187.8% upsideOpen
2022-06-23B.Riley FinancialNeil Chatterji$6331.7% upsideOpen

Stereotaxis (STXS) FAQ

The latest target price for STXS is $3.5. Investors often review this figure alongside Stereotaxis's historical trend and sector peers before judging valuation or financial health.

Stereotaxis trades near $1.39 while the consensus target sits at $3.5 (151.8% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting STXS's target price ($3.5), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Stereotaxis's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.